C

Classys Inc
KOSDAQ:214150

Watchlist Manager
Classys Inc
KOSDAQ:214150
Watchlist
Price: 50 100 KRW 2.56%
Market Cap: 3.3T KRW
Have any thoughts about
Classys Inc?
Write Note

Classys Inc
Net Issuance of Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Classys Inc
Net Issuance of Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
C
Classys Inc
KOSDAQ:214150
Net Issuance of Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dentium Co Ltd
KRX:145720
Net Issuance of Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Biodyne Co Ltd
KOSDAQ:314930
Net Issuance of Common Stock
â‚©203m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
Jeisys Medical Inc
KOSDAQ:287410
Net Issuance of Common Stock
-â‚©4.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
L
Lutronic Corp
KOSDAQ:085370
Net Issuance of Common Stock
â‚©364.4m
CAGR 3-Years
N/A
CAGR 5-Years
14%
CAGR 10-Years
N/A
V
Viol Co Ltd
KOSDAQ:335890
Net Issuance of Common Stock
-â‚©2.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Classys Inc
Glance View

Market Cap
3.2T KRW
Industry
Health Care

Classys Inc., a South Korean powerhouse in the world of aesthetic medical devices, has carved a niche for itself by capitalizing on the soaring demand for non-invasive beauty treatments. Founded in 2007, the company quickly identified a growing market shift towards minimally invasive procedures, and leveraged its technological prowess to develop cutting-edge solutions. Focusing on continuous innovation, Classys has developed a robust portfolio of high-quality products, including popular devices like Clatuu Alpha for fat reduction and Ultraformer for skin lifting. These devices cater to clinics and professionals seeking reliable, effective solutions for their clients' aesthetic needs. The company strategically invests in research and development to stay ahead in this highly competitive sector, continually upgrading its offerings to suit market trends. Operating in over 60 countries, Classys has effectively harnessed the power of global distribution networks and strategic partnerships to bolster its market presence. The company's business model primarily revolves around direct sales and distribution agreements, generating revenue by selling advanced aesthetic devices to medical professionals, clinics, and distributors worldwide. By providing training and after-sales services, Classys ensures customer satisfaction and fosters long-term relationships, which are crucial for repeat business. Additionally, its strong emphasis on compliance with international safety standards and certifications has bolstered its reputation, enabling the company to expand its footprint in emerging markets. This strategic approach has allowed Classys to maintain steady growth in an industry where technological advancements and consumer preferences are in constant flux.

Intrinsic Value
44 512.01 KRW
Overvaluation 11%
Intrinsic Value
Price
C

See Also

Back to Top